Paul C Nathan1,2, Mohammad Agha3, Jason D Pole4, David Hodgson5, Astrid Guttmann6,3, Rinku Sutradhar3, Mark L Greenberg6,4. 1. Department of Pediatrics, The Hospital for Sick Children, Toronto, ON, Canada. paul.nathan@sickkids.ca. 2. Division of Hematology/Oncology, The Hospital for Sick Children, 555 University Avenue, Toronto, Ontario, M5G 1X8, Canada. paul.nathan@sickkids.ca. 3. The Institute for Clinical Evaluative Sciences, Toronto, ON, Canada. 4. The Pediatric Oncology Group of Ontario (POGO), Toronto, ON, Canada. 5. Princess Margaret Cancer Center, Toronto, ON, Canada. 6. Department of Pediatrics, The Hospital for Sick Children, Toronto, ON, Canada.
Abstract
PURPOSE: The purpose of the present study is to determine predictors of attendance at a network of publicly funded specialized survivor clinics by a population-based cohort of adult survivors of childhood cancer. METHODS: We conducted a retrospective study linking data on eligible patients identified in a provincial pediatric cancer registry with health administrative databases to determine attendance at five specialized survivor clinics in the Canadian province of Ontario between 1999 and 2012. Eligible survivors were treated for cancer at ≤18 years between 1986 and 2005, had survived ≥5 years from their most recent pediatric cancer event, and contributed ≥1 year of follow-up after age 18 years. We assessed the impact of cancer type, treatment intensity, cumulative chemotherapy doses, radiation, socioeconomic status, distance to nearest clinic, and care from a primary care physician (PCP) on attendance using recurrent event multivariable regression. RESULTS: Of 7482 children and adolescents treated for cancer over the study period, 3972 were eligible for study inclusion, of which 3912 successfully linked to administrative health data. After a median of 7.8 years (range 0.2-14.0) of follow-up, 1695/3912 (43.3 %) had attended at least one adult survivor clinic visit. Significantly increased rates of attendance were associated with female gender, higher treatment intensity, radiation, higher alkylating agent exposure, higher socioeconomic status, and an annual exam by a PCP. Distance significantly impacted attendance with survivors living >50 km away less likely to attend than those living within 10 km (relative rate 0.77, p = 0.003). CONCLUSION: Despite free access to survivor clinics, the majority of adult survivors of childhood cancer do not attend. IMPLICATIONS FOR CANCER SURVIVORS: Alternate models of care need to be developed and assessed, particularly for survivors living far from a specialized clinic and those at lower risk of developing late effects.
PURPOSE: The purpose of the present study is to determine predictors of attendance at a network of publicly funded specialized survivor clinics by a population-based cohort of adult survivors of childhood cancer. METHODS: We conducted a retrospective study linking data on eligible patients identified in a provincial pediatric cancer registry with health administrative databases to determine attendance at five specialized survivor clinics in the Canadian province of Ontario between 1999 and 2012. Eligible survivors were treated for cancer at ≤18 years between 1986 and 2005, had survived ≥5 years from their most recent pediatric cancer event, and contributed ≥1 year of follow-up after age 18 years. We assessed the impact of cancer type, treatment intensity, cumulative chemotherapy doses, radiation, socioeconomic status, distance to nearest clinic, and care from a primary care physician (PCP) on attendance using recurrent event multivariable regression. RESULTS: Of 7482 children and adolescents treated for cancer over the study period, 3972 were eligible for study inclusion, of which 3912 successfully linked to administrative health data. After a median of 7.8 years (range 0.2-14.0) of follow-up, 1695/3912 (43.3 %) had attended at least one adult survivor clinic visit. Significantly increased rates of attendance were associated with female gender, higher treatment intensity, radiation, higher alkylating agent exposure, higher socioeconomic status, and an annual exam by a PCP. Distance significantly impacted attendance with survivors living >50 km away less likely to attend than those living within 10 km (relative rate 0.77, p = 0.003). CONCLUSION: Despite free access to survivor clinics, the majority of adult survivors of childhood cancer do not attend. IMPLICATIONS FOR CANCER SURVIVORS: Alternate models of care need to be developed and assessed, particularly for survivors living far from a specialized clinic and those at lower risk of developing late effects.
Entities:
Keywords:
Administrative health databases; Cancer registries; Childhood cancer survivors; Models of care; Survivor clinics
Authors: Melissa M Hudson; Wendy Leisenring; Kayla K Stratton; Nina Tinner; Brenda D Steen; Susan Ogg; Linda Barnes; Kevin C Oeffinger; Leslie L Robison; Cheryl L Cox Journal: J Clin Oncol Date: 2014-11-03 Impact factor: 44.544
Authors: Kevin C Oeffinger; Keith E Argenbright; Gill A Levitt; Mary S McCabe; Paula R Anderson; Emily Berry; Jane Maher; Janette Merrill; Dana S Wollins Journal: Am Soc Clin Oncol Educ Book Date: 2014
Authors: Siobhan M Phillips; Lynne S Padgett; Wendy M Leisenring; Kayla K Stratton; Ken Bishop; Kevin R Krull; Catherine M Alfano; Todd M Gibson; Janet S de Moor; Danielle Blanch Hartigan; Gregory T Armstrong; Leslie L Robison; Julia H Rowland; Kevin C Oeffinger; Angela B Mariotto Journal: Cancer Epidemiol Biomarkers Prev Date: 2015-04 Impact factor: 4.254
Authors: Paul C Nathan; Mark L Greenberg; Kirsten K Ness; Melissa M Hudson; Ann C Mertens; Martin C Mahoney; James G Gurney; Sarah S Donaldson; Wendy M Leisenring; Leslie L Robison; Kevin C Oeffinger Journal: J Clin Oncol Date: 2008-09-20 Impact factor: 50.717
Authors: Judy Y Ou; Rochelle R Smits-Seemann; Yelena P Wu; Jennifer Wright; Anne C Kirchhoff Journal: J Cancer Surviv Date: 2017-11-29 Impact factor: 4.442
Authors: Katie A Devine; Adrienne Viola; Peter Capucilli; Olle Jane Z Sahler; Jeffrey R Andolina Journal: J Pediatr Hematol Oncol Date: 2017-04 Impact factor: 1.289
Authors: Kristin C Marr; Mohammad Agha; Rinku Sutradhar; Jason D Pole; David Hodgson; Astrid Guttmann; Mark Greenberg; Paul C Nathan Journal: J Cancer Surviv Date: 2017-08-07 Impact factor: 4.442
Authors: Beeshman S Nandakumar; Joanna E Fardell; Claire E Wakefield; Christina Signorelli; Jordana K McLoone; Jane Skeen; Ann M Maguire; Richard J Cohn Journal: Support Care Cancer Date: 2018-03-02 Impact factor: 3.603
Authors: Kelley K Hutchins; Süreyya Savaşan; Ronald L Thomas; Laura A Strathdee; Zhihong J Wang; Jeffrey W Taub Journal: J Pediatr Hematol Oncol Date: 2019-01 Impact factor: 1.289
Authors: K Reynolds; M Spavor; Y Brandelli; C Kwok; Y Li; M Disciglio; L E Carlson; F Schulte; R Anderson; P Grundy; J Giese-Davis Journal: J Cancer Surviv Date: 2019-06-27 Impact factor: 4.442
Authors: Pam Baker DeGuzman; David L Vogel; Bethany Horton; Veronica Bernacchi; C Allen Cupp; B J Ferrebee Ghamandi; Ivora D Hinton; Christi Sheffield; Mark J Jameson Journal: J Cancer Surviv Date: 2021-05-13 Impact factor: 4.062
Authors: Alina Zgardau; Joel G Ray; Nancy N Baxter; Chenthila Nagamuthu; Alison L Park; Sumit Gupta; Paul C Nathan Journal: J Natl Cancer Inst Date: 2022-04-11 Impact factor: 13.506